You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
一場嚴肅醫療與消費醫療的碰撞 | 早篩賽道風口已至,未來已來!
格隆匯 08-19 21:36

醫療行業本質是治病救人,屬於剛需領域,這也決定了其有嚴格的規範,消費者的決策往往依託的是醫生與患者的強信任紐帶,這也是嚴肅醫療的基本特徵所在。而相對來説,在消費醫療上,更多的主動權在消費者手中,比如醫美、口腔這類,其並非某種必需品。癌症篩查則剛好處在兩者的臨界點,因此如何將兩者有機鏈接,也成為了癌症早篩公司必須下功夫的地方。

換言之,在談癌色變的大背景下,癌症早篩必須要經得起合規的考驗,帶給消費者足夠的安全感和信任感,這也是腫瘤早篩類產品與服務能否在市場上站穩腳跟的關鍵。但同時,市場教育不夠的情況下,消費者對癌症篩查的重要性仍然還有認知偏差,如何撬動這部分需求,則更需要從消費醫療的視角去突破。當前,癌症早篩的應用已經從醫院場景關口前移至居家場景,成為健康新消費一股勢不可擋的“新勢力”。

正值港股迎來中報密集發佈期,投資者如何挖掘早篩賽道的投資機遇?面對新健康時代的來臨,癌症早篩產品又該如何抓住客户的需求,讓消費者為之買單?

針對這些問題,格隆匯將在8月22日舉辦一場關於“健康新消費:癌症早篩跨界消費醫療,如何引領健康新消費?”的線上會議。與會嘉賓也將特別就居家檢測難點、要點以及前景進行專題解讀分享,與投資人共話癌症早篩市場的發展與未來投資機遇。

活動時間:2022年8月22日(週一)14:30-16:40

活動形式:線上參會

參會方式:格隆匯APP視頻號,匯路演

問答參與:

1、對諾輝健康的產品及未來有什麼想了解?

2、您覺得癌症早篩的痛點和難點是什麼?您會主動做早篩嗎?

* 您也可在本文下方進行留言,提出您想了解的問題。我們將隨機抽取部分問題在直播現場進行解答。被選中的提問也將獲得由諾輝健康贈送的禮品一份!歡迎各位讀者及投資人踴躍參與提問~~

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account